Livazo 1 coated tablets 1 mg. №30

$59.00

Purpose: Reduces cholesterol by inhibiting HMG-CoA reductase enzyme. Treats hyperlipidemia.

SKU: MED59321 Category:

Description

Livazo 1 Coated Tablets 1 mg. №30

Ingredients:

Each coated tablet contains 1 mg of Pitavastatin.

Dosage:

The usual dose is 1 mg once daily. It can be taken with or without food.

Indications:

Livazo is indicated as an adjunctive therapy to diet to reduce elevated total cholesterol, low-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and to increase high-density lipoprotein cholesterol.

Contraindications:

Do not use Livazo if you have a known hypersensitivity to Pitavastatin or any component of this medication. It is contraindicated in patients with active liver disease or unexplained persistent elevations of serum transaminases.

Directions:

Swallow the tablet whole with a glass of water. Do not crush or chew the tablet. Follow the instructions of your healthcare provider.

Scientific Evidence:

Studies have shown that Pitavastatin, the active ingredient in Livazo, effectively reduces LDL cholesterol levels and has a favorable safety profile. Research published in the Journal of Clinical Lipidology demonstrated the efficacy of Pitavastatin in improving lipid profiles in patients with dyslipidemia.

Additional Information:

Livazo is generally well-tolerated, but common side effects may include muscle pain, weakness, and stomach pain. It is important to monitor liver function tests during treatment with Livazo.

Pharmacologically, Pitavastatin works by inhibiting HMG-CoA reductase, the enzyme responsible for cholesterol synthesis in the liver. By reducing cholesterol production, Pitavastatin helps lower LDL levels and decrease the risk of cardiovascular events.

Compared to other statins, Pitavastatin has shown similar efficacy in lowering cholesterol levels with potentially fewer drug interactions. Clinical trials have also indicated its effectiveness in reducing the progression of atherosclerosis and improving cardiovascular outcomes.